Cilastatin Sodium Market Size, Share & Growth Statistcs Report to 2030

Cilastatin Sodium Market Size, Share, Growth Trends, Industry Analysis and Forecast to 2030

Report ID: RC135551 | Report Format: PDF + Excel | Last Updated: August 25th, 2025

The global cilastatin sodium market size was accounted for around USD 900 million in 2024 and expected to grow at a significant CAGR of 3% during the forecast period 2025 to 2030. The increasing incidence of lower respiratory tract infections is a primary factor driving the market growth. Furthermore, the growing number of urinary tract infection patients across the globe is projected to boost the market over the forecast period.

Market Snapshot:

Benchmark Year		2024
Market Size		~ USD 900 Million in 2024
Market Growth (CAGR)		~ 3% (2025-2030)
Largest Market Share		North America
Analysis Period		2020-2030
Market Players		Fresenius Kabi, Pfizer, Inc., Sandoz, Inc., Merck KGaA., and Enzo Life Sciences, Inc.

Industry Trends Shaping the Global Cilastatin Sodium Market

The cilastatin sodium market is experiencing key trends driven by the rising prevalence of severe bacterial infections and the growing need for effective antibiotic therapies. As cilastatin sodium is widely used in combination with imipenem to prevent the breakdown of the antibiotic in the kidneys, its demand is closely tied to the increasing use of carbapenem antibiotics for multidrug-resistant (MDR) infections. The rise in hospital-acquired infections (HAIs), particularly in intensive care units, is further fueling adoption. Additionally, the growing burden of antimicrobial resistance is pushing healthcare providers to rely more on last-line treatments like imipenem/cilastatin, strengthening the market outlook.

Another important trend is the growing emphasis on research and development of advanced antibiotic combinations that improve efficacy and reduce resistance risks. Pharmaceutical companies are focusing on expanding the availability of cilastatin sodium across emerging markets, where the incidence of infectious diseases is high and healthcare infrastructure is rapidly improving. Moreover, increasing regulatory approvals and the inclusion of such drugs in essential medicines lists are enhancing accessibility. The trend toward generic formulations is also gaining momentum, making cilastatin sodium more affordable and widening its usage across hospitals and clinics worldwide.

Cilastatin Sodium Market Key Drivers:

Increasing Prevalence of Bacterial Infections: Bacterial infections are a significant global health concern, and the prevalence of these infections is increasing. Cilastatin sodium is commonly used in combination with the antibiotic drug imipenem to treat severe bacterial infections, including respiratory, urinary tract, and intra-abdominal infections. The growing incidence of bacterial infections is driving the demand for cilastatin sodium.
Rising Antibiotic Resistance: Antibiotic resistance is a critical healthcare issue, leading to treatment failures and increased mortality rates. Cilastatin sodium, as part of the imipenem-cilastatin combination, helps address antibiotic resistance by improving the effectiveness of imipenem against resistant bacteria. The need for effective antibiotics to combat multidrug-resistant bacteria is driving the demand for cilastatin sodium.
Growing Geriatric Population: The aging population is susceptible to various infections, and the incidence of severe bacterial infections tends to be higher among older adults. As the global geriatric population continues to grow, there is an increased demand for medications like cilastatin sodium to address bacterial infections commonly found in this demographic.
Hospital Acquired Infections: Hospital-acquired infections (HAIs) pose a significant risk to patients and can lead to prolonged hospital stays, increased healthcare costs, and higher mortality rates. Cilastatin sodium, in combination with imipenem, is commonly used to treat HAIs. The increasing focus on infection control and prevention in healthcare facilities drives the demand for cilastatin sodium.
Advancements in Healthcare Infrastructure: Advances in healthcare infrastructure, particularly in developing countries, contribute to the growth of the cilastatin sodium market. Improved access to healthcare facilities, better diagnostic capabilities, and increased availability of antibiotics drive the demand for cilastatin sodium in these regions.
Rising Healthcare Expenditure: Increasing healthcare expenditure, driven by factors such as population growth, improved access to healthcare services, and rising income levels, supports the demand for cilastatin sodium. Healthcare systems’ ability to invest in advanced medications and treatment options, including cilastatin sodium, contributes to market growth.
Favorable Regulatory Environment: A supportive regulatory environment plays a crucial role in the availability and use of cilastatin sodium. Regulatory agencies ensure the safety, quality, and efficacy of pharmaceutical products, including cilastatin sodium. The presence of clear regulations and guidelines facilitates the development, approval, and commercialization of cilastatin sodium, boosting market growth.

Cilastatin Sodium Market Opportunities:

The cilastatin sodium market presents significant opportunities driven by the rising global burden of bacterial infections and the increasing use of broad-spectrum antibiotics. With the growing challenge of antimicrobial resistance, the demand for cilastatin as a companion drug to imipenem is expanding, particularly in hospital settings where multidrug-resistant infections are prevalent. Additionally, emerging economies are witnessing rapid healthcare infrastructure development and improved access to advanced antibiotics, creating fresh demand opportunities for cilastatin sodium in Asia-Pacific and Latin America.

A key market-shaping opportunity comes from innovative repurposing efforts. In February 2024, Arch Biopartners Inc. announced discussions with the U.S. FDA to repurpose cilastatin as a standalone treatment for preventing acute kidney injury (AKI), beyond its traditional role with imipenem. This breakthrough could open entirely new therapeutic markets for cilastatin, extending its use into nephrology and critical care. If clinical trials succeed, it would not only diversify applications but also attract strategic collaborations, regulatory incentives, and investment from pharmaceutical companies, significantly broadening the commercial scope of the cilastatin sodium market.

Market Segment Insights:

The global cilastatin sodium market is segmented on the basis of clinical application, distribution channel, and geography. On the basis of clinical application, the segment is divided into lower respiratory tract infections, urinary tract infections, and other applications. The lower respiratory tract infection segment held the largest market share in 2020. As per a research study shared by WHO, 1.4 million people die each year due to tuberculosis across the globe. Furthermore, pneumonia is a leading cause of children’s death below the age of 5 years around the world. In contrast, the urinary tract infection segment is accounted to grow at a significant growth rate over the forecast period due to the increasing water population owing to rapid urbanization.

By region, North America dominated the global cilastatin sodium market in 2024. The rising incidence of lower respiratory tract infection is a key factor to drive market growth in the region. As per the latest information shared by NIH (National Institute of Health), the prevalence rate of lower respiratory tract infections in children is accounted for around 5.7% in the United States each year. Furthermore, the affordable reimbursement scenario associated with the medicinal use of cisplatin sodium enhances the growth of the market in the region. In contrast, Europe is accounted for the second-largest region for cilastatin sodium market share due to the increasing number of urinary tract infections among all age group people in the region.

Global Cilastatin Sodium Market Size and Forecast

To know more about the study, request a report sample

Global cilastatin sodium market size and forecast were obtained by using “Bottom-up” and “Top-down” approaches. Extensive secondary research was conducted to understand the market insights and trends, followed by primary interviews to further validate the information sourced. The report provides both, qualitative and quantitative analyses of the market, the competitive landscape, and the preferred development strategies of key players which help to formulate competitive market strategies and make informed decisions.

Cilastatin Sodium Market Segmentation:

By Clinical Application:

Lower Respiratory Tract Infections
Urinary Tract Infections
Others

By Distribution Channel:

Hospital Pharmacy
Retail Pharmacy
Others

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Geographic Coverage: North America Leads the Cilastatin Sodium Market

Geographically, the cilastatin sodium market report comprises dedicated sections centering on the regional market revenue and trends. The cilastatin sodium market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, and Rest of the World (RoW). The RoW segment consists of Latin America and the Middle East & Africa. The market has been extensively analyzed on the basis of various regional factors such as demographics, gross domestic product (GDP), inflation rate, acceptance, and others. The market estimates have also been provided for the historical years 2018 & 2019 along with forecasts for the period from 2021 – 2027.

Cilastatin Sodium Market Competition Assessment:

Key players operating in the global cilastatin sodium market are Fresenius Kabi, Pfizer, Inc. , Sandoz, Inc., Merck KGaA., and Enzo Life Sciences, Inc. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

Fresenius Kabi
Pfizer, Inc.
Sandoz, Inc.
Merck KGaA
Enzo Life Sciences, Inc.
Taiwan Biotech
Teva Pharmaceutical Industries Limited
Mylan Pharmaceutical Industries Limited
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceutical Industries Ltd.

Key Questions Answered by Cilastatin Sodium Market Report:

Global cilastatin sodium market forecasts from 2021-2027
Regional cilastatin sodium market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
Cilastatin sodium submarket forecasts from 2021-2027 covering the market by clinical application, by distribution channel, and geography
Various industry models such as SWOT analysis, Value Chain Analysis pertaining to the market
Analysis of the key factors driving and restraining the growth of the global, regional and country-level markets from 2021-2027
Competitive Landscape and market positioning of top 10 players operating in the market

Table of Content:

1. Preface

1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

2. Executive Summary

2.1. Global Cilastatin Sodium Market Portraiture
2.2. Global Cilastatin Sodium Market, by Clinical Application, 2020 (USD Mn)
2.3. Global Cilastatin Sodium Market, by Distribution Channel, 2020 (USD Mn)
2.4. Global Cilastatin Sodium Market, by Geography, 2020 (USD Mn)

3. Global Cilastatin Sodium Market Analysis

3.1. Cilastatin Sodium Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis

4. Global Cilastatin Sodium Market By Clinical Application, 2018 – 2027 (USD Mn)

4.1. Overview
4.2. Lower Respiratory Tract Infections
4.3. Urinary Tract Infections
4.4. Others

5. Global Cilastatin Sodium Market By Distribution Channel, 2018 – 2027 (USD Mn)

5.1. Overview
5.2. Hospital Pharmacy
5.3. Retail Pharmacy
5.4. Others

6. Global Cilastatin Sodium Market, By Geography, 2018 – 2027 (USD Mn)

6.1. Introduction
6.2. North America
6.2.1. Overview
6.2.2. North America Cilastatin Sodium Market by Clinical Application (2018-2027 USD Mn)
6.2.3. North America Cilastatin Sodium Market by Distribution Channel (2018-2027 USD Mn)
6.2.4. North America Cilastatin Sodium Market by Country (2018-2027 USD Mn)
6.2.4.1. U.S.
6.2.4.2. Canada
6.3. Europe
6.3.1. Overview
6.3.2. Europe Cilastatin Sodium Market by Clinical Application (2018-2027 USD Mn)
6.3.3. Europe Cilastatin Sodium Market by Distribution Channel (2018-2027 USD Mn)
6.3.4. Europe Cilastatin Sodium Market by Country (2018-2027 USD Mn)
6.3.4.1. Germany
6.3.4.2. U.K.
6.3.4.3. France
6.3.4.4. Italy
6.3.4.5. Rest of Europe
6.4. Asia Pacific
6.4.1. Overview
6.4.2. Asia Pacific Cilastatin Sodium Market by Clinical Application (2018-2027 USD Mn)
6.4.3. Asia Pacific Cilastatin Sodium Market by Distribution Channel (2018-2027 USD Mn)
6.4.4. Asia Pacific Cilastatin Sodium Market by Country (2018-2027 USD Mn)
6.4.4.1. China.
6.4.4.2. Japan
6.4.4.3. Rest of Asia Pacific
6.5. Latin America (LATAM)
6.5.1. Overview
6.5.2. Latin America Cilastatin Sodium Market by Clinical Application (2018-2027 USD Mn)
6.5.3. Latin America Cilastatin Sodium Market by Distribution Channel (2018-2027 USD Mn)
6.5.4. Latin America Cilastatin Sodium Market by Country (2018-2027 USD Mn)
6.5.4.1. Brazil
6.5.4.2. Mexico
6.5.4.3. Rest of Latin America
6.6. Middle East and Africa
6.6.1. Overview
6.6.2. MEA Cilastatin Sodium Market by Clinical Application (2018-2027 USD Mn)
6.6.3. MEA Cilastatin Sodium Market by Distribution Channel (2018-2027 USD Mn)
6.6.4. Middle East and Africa Cilastatin Sodium Market, by Country (2018-2027 USD Mn)
6.6.4.1. GCC
6.6.4.2. Rest of MEA

7. Company Profiles

7.1. Fresenius Kabi
7.1.1. Business Description
7.1.2. Financial Health and Budget Allocation
7.1.3. Product Positions/Portfolio
7.1.4. Recent Development
7.1.5. SWOT Analysis
7.2. Pfizer, Inc.
7.2.1. Business Description
7.2.2. Financial Health and Budget Allocation
7.2.3. Product Positions/Portfolio
7.2.4. Recent Development
7.2.5. SWOT Analysis
7.3. Sandoz, Inc.
7.3.1. Business Description
7.3.2. Financial Health and Budget Allocation
7.3.3. Product Positions/Portfolio
7.3.4. Recent Development
7.3.5. SWOT Analysis
7.4. Merck KGaA
7.4.1. Business Description
7.4.2. Financial Health and Budget Allocation
7.4.3. Product Positions/Portfolio
7.4.4. Recent Development
7.4.5. SWOT Analysis
7.5. Enzo Life Sciences, Inc.
7.5.1. Business Description
7.5.2. Financial Health and Budget Allocation
7.5.3. Product Positions/Portfolio
7.5.4. Recent Development
7.5.5. SWOT Analysis
7.6. Taiwan Biotech
7.6.1. Business Description
7.6.2. Financial Health and Budget Allocation
7.6.3. Product Positions/Portfolio
7.6.4. Recent Development
7.6.5. SWOT Analysis
7.7. Teva Pharmaceutical Industries Limited
7.7.1. Business Description
7.7.2. Financial Health and Budget Allocation
7.7.3. Product Positions/Portfolio
7.7.4. Recent Development
7.7.5. SWOT Analysis
7.8. Mylan Pharmaceutical Industries Limited
7.8.1. Business Description
7.8.2. Financial Health and Budget Allocation
7.8.3. Product Positions/Portfolio
7.8.4. Recent Development
7.8.5. SWOT Analysis
7.9. Glenmark Pharmaceuticals Ltd.
7.9.1. Business Description
7.9.2. Financial Health and Budget Allocation
7.9.3. Product Positions/Portfolio
7.9.4. Recent Development
7.9.5. SWOT Analysis
7.10. Sun Pharmaceutical Industries Ltd.
7.10.1. Business Description
7.10.2. Financial Health and Budget Allocation
7.10.3. Product Positions/Portfolio
7.10.4. Recent Development
7.10.5. SWOT Analysis

To know more about the study, request a report sample

List of Tables:

TABLE 1 Market Snapshot: Global Cilastatin Sodium Market

TABLE 2                Impact Indicators

TABLE 3                Impact Analysis of Drivers and Challenges

TABLE 4                Global Cilastatin Sodium Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 5                Global Cilastatin Sodium Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 6 North America Cilastatin Sodium Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 7 North America Cilastatin Sodium Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 8 North America Cilastatin Sodium Market Value, By Country, 2018 - 2027 (US$ Mn)

TABLE 9 U.S. Cilastatin Sodium Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 10 U.S. Cilastatin Sodium Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 11 Canada Cilastatin Sodium Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 12 Canada Cilastatin Sodium Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 13 Europe Cilastatin Sodium Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 14 Europe Cilastatin Sodium Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 15 Europe Cilastatin Sodium Market Value, by Country, 2018 - 2027 (US$ Mn)

TABLE 16 Germany Cilastatin Sodium Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 17 Germany Cilastatin Sodium Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 18 U.K. Cilastatin Sodium Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 19 U.K. Cilastatin Sodium Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 20 France Cilastatin Sodium Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 21 France Cilastatin Sodium Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 22 Italy Cilastatin Sodium Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 23 Italy Cilastatin Sodium Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 24 Rest of Europe Cilastatin Sodium Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 25 Rest of Europe Cilastatin Sodium Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 26 Asia Pacific Cilastatin Sodium Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 27 Asia Pacific Cilastatin Sodium Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 28 Asia Pacific Cilastatin Sodium Market Value, by Country, 2018 - 2027 (US$ Mn)

TABLE 29 Japan Cilastatin Sodium Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 30 Japan Cilastatin Sodium Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 31 China Cilastatin Sodium Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 32 China Cilastatin Sodium Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 33 Rest of Asia Pacific Cilastatin Sodium Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 34 Rest of Asia Pacific Cilastatin Sodium Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 35 Latin America Cilastatin Sodium Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 36 Latin America Cilastatin Sodium Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 37 Latin America Cilastatin Sodium Market Value, by Country, 2018 - 2027 (US$ Mn)

TABLE 38 Brazil Cilastatin Sodium Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 39 Brazil Cilastatin Sodium Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 40 Mexico Cilastatin Sodium Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 41 Mexico Cilastatin Sodium Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 42 Rest of Latin America Cilastatin Sodium Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 43 Rest of Latin America Cilastatin Sodium Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 44 Middle East & Africa Cilastatin Sodium Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 45 Middle East & Africa Cilastatin Sodium Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 46 Middle East & Africa Cilastatin Sodium Market Value, by Country, 2018 - 2027 (US$ Mn)

TABLE 47 GCC Cilastatin Sodium Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 48 GCC Cilastatin Sodium Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 49 Rest of MEA Cilastatin Sodium Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 50 Rest of MEA Cilastatin Sodium Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 51 Fresenius Kabi: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 52 Pfizer, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 53 Sandoz, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 54 Merck KGaA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 55 Enzo Life Sciences, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 56 Taiwan Biotech: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 57 Teva Pharmaceutical Industries Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 58 Mylan Pharmaceutical Industries Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 59 Glenmark Pharmaceuticals Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 60 Sun Pharmaceutical Industries Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 61 Medisafe: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

To know more about the study, request a report sample

List of Figures:

FIG. 1 Global Cilastatin Sodium: Market Segmentation

FIG. 2 Global Cilastatin Sodium Market: Research Methodology

FIG. 3 Top-Down and Bottom-up Approach

FIG. 4 Global Cilastatin Sodium Market, by Clinical Application, 2019 (US$ Mn)

FIG. 5 Global Cilastatin Sodium Market, by Distribution Channel, 2019 (US$ Mn)

FIG. 6 Global Cilastatin Sodium Market, by Geography, 2019 (US$ Mn)

FIG. 7 Global Cilastatin Sodium Market Value and Growth, 2018 – 2027, (US$ Mn) (Y-o-Y %)

FIG. 8 Attractive Investment Proposition, by Geography, 2017

FIG. 9 Market Positioning of Key Cilastatin Sodium Providers, 2019

FIG. 10 Global Cilastatin Sodium Market Value Share, by Clinical Application, 2018 & 2027 (%)

FIG. 11 Global Cilastatin Sodium Market Value for Lower Respiratory Tract Infections, 2018 - 2027, (US$ Mn)

FIG. 12 Global Cilastatin Sodium Market Value for Urinary Tract Infections 2018 - 2027, (US$ Mn)

FIG. 13 Global Cilastatin Sodium Market Value for Others, 2018 - 2027, (US$ Mn)

FIG. 14 Global Cilastatin Sodium Market Value Share, by Distribution Channel, 2018 & 2027 (Value %)

FIG. 15 Global Cilastatin Sodium Market Value for Hospital Pharmacy, 2018 - 2027, (US$ Mn)

FIG. 16 Global Cilastatin Sodium Market Value for Retail Pharmacy, 2018 - 2027, (US$ Mn)

FIG. 17 Global Cilastatin Sodium Market Value for Others, 2018 - 2027, (US$ Mn)

FIG. 18 North America Cilastatin Sodium Market Value, 2018 - 2027, (US$ Mn)

FIG. 19 Europe Cilastatin Sodium Market Value, 2018 - 2027, (US$ Mn)

FIG. 20 Asia Pacific Cilastatin Sodium Market Value, 2018 - 2027, (US$ Mn)

FIG. 21 LATIN America Cilastatin Sodium Market Value, 2018 - 2027, (US$ Mn)

FIG. 22 Middle East & Africa Cilastatin Sodium Market Value, 2018 - 2027, (US$ Mn)

Fill the given form to inquiry before buying for Cilastatin Sodium Market Report

Download Sample Papers

Inquiry Before Buying

Schedule a Call

Select License Type

$ 3650/- Single User License
$ 5200/- Multi User License
$ 6950/- Corporate License